Correlation Between Bank of America and Akari Therapeutics

Can any of the company-specific risk be diversified away by investing in both Bank of America and Akari Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bank of America and Akari Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bank of America and Akari Therapeutics PLC, you can compare the effects of market volatilities on Bank of America and Akari Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bank of America with a short position of Akari Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bank of America and Akari Therapeutics.

Diversification Opportunities for Bank of America and Akari Therapeutics

0.35

Correlation Coefficient

Bank of America  Akari Therapeutics

Weak diversification

The 3 months correlation between Bank and Akari is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Bank of America and Akari Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akari Therapeutics PLC and Bank of America is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bank of America are associated (or correlated) with Akari Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akari Therapeutics PLC has no effect on the direction of Bank of America i.e., Bank of America and Akari Therapeutics go up and down completely randomly.

Pair Corralation between Bank of America and Akari Therapeutics

Considering the 90-day investment horizon Bank of America is expected to under-perform the Akari Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Bank of America is 4.82 times less risky than Akari Therapeutics. The stock trades about -0.02 of its potential returns per unit of risk. The Akari Therapeutics PLC is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  97.00  in Akari Therapeutics PLC on December 27, 2024 and sell it today you would earn a total of  34.00  from holding Akari Therapeutics PLC or generate 35.05% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Bank of America  vs.  Akari Therapeutics PLC

Bank of America

Risk-Adjusted Performance

Very Weak

Over the last 90 days Bank of America has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Bank of America is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Akari Therapeutics PLC

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Akari Therapeutics PLC are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Akari Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Bank of America and Akari Therapeutics

The main advantage of trading using opposite Bank of America and Akari Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bank of America position performs unexpectedly, Akari Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akari Therapeutics will offset losses from the drop in Akari Therapeutics' long position.

The idea behind Bank of America and Akari Therapeutics PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.